Generic Name and Formulations:
Gatifloxacin 0.5%; oph soln; contains benzalkonium chloride.
Indications for ZYMAXID:
Susceptible bacterial conjunctivitis.
Adults and Children:
<1yr: not established. ≥1yr: 1 drop every 2hrs in affected eye(s) while awake (max 8 doses) on day 1, then 1 drop in affected eye(s) 2–4 times daily while awake on days 2–7.
Discontinue if superinfection or hypersensitivity occurs. Corneal endothelial cell injury. Pregnancy. Nursing mothers.
Worsening conjunctivitis, irritation, dysgeusia, eye pain/discharge.
Endocrinology Advisor Articles
- Testosterone Use Remains High Among Men With Coronary Artery Disease
- Higher Risk for Venous Thromboembolism With Oral vs Transdermal HRT
- Comparing Osteoporosis Screening, Treatment Strategies in Postmenopausal Women
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Free vs Total Serum 25(OH)D as Biomarkers for Bone Health in Older Women
- ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Diabetic Ketoacidosis May Affect Brain Development in Children With T1D
- Higher Rates of Comorbidities Among Holocaust Survivors
- Population Health Data May Help Identify Patients at Risk for CVD
- Newborn Genomic Sequencing Can Identify Disease Risk